ArticleBiotechnology and applied biochemistry2026
Unraveling the Time-Dependent Effects of Ethanol on Liver Disease: Insights From a Mice Model.
Article in Biotechnology and applied biochemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Alcohol-associated liver disease (ALD) is a significant global health concern that is characterized by hepatic triglyceride accumulation and dysregulation with impairment of oxygen homeostasis. This study investigated the time-dependent effects of ethanol exposure on liver disease progression in 2-month-old male C57/BL6 mice. Mice were treated with ethanol (20% ethanol at 5 gm/kg.b.wt/day) for 2, 4, and 6 months, and blood biochemical markers, liver histopathology, and gene expression were evaluated. Results showed that ethanol exposure led to significant increases in thiobarbituric acid reactive substances (TBARS), protein carbonyls, plasma nitric oxide (NOx), C-reactive protein, and homocysteine, liver enzymes, such as aspartate aminotransferase (AST), alanine aminotransferase (ALT), alkaline phosphatase (ALP), gamma-glutamyl transferase (γ-GT), lactate dehydrogenase (LDH) indicating oxidative stress and liver injury. Lipid profile analysis revealed increased total cholesterol and triglycerides, with decreased HDL-cholesterol. Moreover, reduced mitochondrial enzyme activity indicates dysfunction. Histopathology and qRT-PCR analysis showed increased CYP2E1, Bax, Bcl2, p53, caspase-3, caspase-9, and inducible nitric oxide synthase (iNOS) gene expression, leading to ROS/RNS generation. The miR-21 was upregulated, while miR-26a was downregulated, contributing to lipid metabolism dysregulation, pro-inflammation, and pro-fibrosis. These findings suggest that ethanol exposure causes triglyceride accumulation and cholesterol dysregulation, leading to oxidative stress, mitochondrial dysfunction, and hepatocellular injury. The dysregulation of miR-21 and miR-26a contributes to ALD progression. Markers of oxidative stress, miRNAs, and disrupted metabolic pathways may serve as potential biomarkers or therapeutic targets for early detection and intervention in ALD.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.